www.newsmax.com
Merck's Potential Blockbuster Cholesterol Pill Succeeds in Late-Stage Studies
Merck's oral cholesterol pill succeeded in two late-stage studies, marking a win for the drugmaker as it focuses on the development of growth drivers beyond its cancer drugs and vaccines.